Scientific Sessions 2026

Sessions examine how endothelial dysfunction, inflammatory signalling and platelet biology interact in atherosclerosis; how physiology and patient outcomes can guide coronary revascularization; and how stem cells and biomaterials could produce living vascular replacements for congenital heart disease. Other discussions address cardiovascular gene therapy, precision medicine, trial design and causal inference, cardiometabolic disease, and the role of AI in cardiovascular care.

The programme runs on 6–9 November 2026 in Central Standard Time (America/Chicago, UTC−06:00). Friday programming begins at 08:00; the Saturday opening keynote is 08:00–08:35; the Nobel Laureate Address is Sunday 09:45–11:00; the meeting closes Monday at 16:15.

Attendance is available in person or virtually. Livestreaming covers selected rooms and sessions, with replays available within 24 hours and through 20 November at 23:59 CST. General nonmember registration costs US$1,499 in person or US$699 virtually; member, early-career and student rates differ. Registration uses an AHA account. Some supplementary symposia require separate registration.